TABLE 1

Demographics and Clinical and Laboratory Results

Patient no.SexAge (y)Duration of Crohn's disease (y)PGA score*CDAIESR (mm/h)CRP (mg/dL)Days between PET/CT and surgery
1M3914.38260172.954
2F40146304604.25
3F311092393NA28
4M4118.2561982722
5F52572189<0.38
6M3123.58195240.764
7F3210.7581731536
8F57>20710241NA12
9M3611.755914<0.363
10F444860140.4148
11M261062129142
12M333726190.352
13M63327228182.312
14M290.23170252.8No surgery
15F594.37200521.3No surgery
16F34∼206296130.5No surgery
17F57>11.584241307No surgery
Median3911.67212150.8528
Range26–630.2–323–960–3043–640.3–72–148
  • * Scale for predicting relative degree of inflammation (1) to fibrosis (10).

  • CDAI ≤ 150, inactive disease; 150–450, active disease; ≥450, severe disease.

  • NA = not available.

  • ESR reference range, 4–25 mm/h; CRP reference range, 0.0–0.5 mg/dL.